Skip to content

Physical Activity in Overweight Girls: Implications for Reversing Risk Factors for Type 2 Diabetes

Physical Activity in Overweight Girls: Implications for Reversing Risk Factors for Type 2 Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01323088
Enrollment
44
Registered
2011-03-25
Start date
2010-08-31
Completion date
2012-10-31
Last updated
2013-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Obesity, Physical Activity

Keywords

Childhood obesity, Visceral fat, Insulin resistance, Liver fat, Skeletal muscle lipid, Regular exercise

Brief summary

In this randomized controlled trial, we will examine the effect of a 3-month exercise training (aerobic exercise versus resistance exercise) without calorie restriction on total and regional adiposity, ectopic fat in the liver and skeletal muscle, and risk of type 2 diabetes in overweight girls.

Interventions

OTHERControl

Standard care control (no exercise)

OTHERResistance Exercise

Supervised resistance exercise using stack weight equipments.

OTHERAerobic exercise

Supervised aerobic exercise using treadmills, bikes, and ellipticals

Sponsors

University of Pittsburgh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
12 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy overweight (BMI \>-95th) youth between 12 and 18 years of age * Waist circumference \>-75th percentile * Sedentary (no structured exercise \>2 times/week for past 6 months) * Non-smokers, non-diabetic, no medical conditions * Weight stable for past 3 months

Exclusion criteria

* Smokers * Diabetes * Psychiatric disorders * Syndromic obesity * Pregnancy * Taking medications known to affect study outcomes

Design outcomes

Primary

MeasureTime frame
Abdominal obesity, visceral fat3 month

Secondary

MeasureTime frame
insulin sensitivity by a 3-hour hyperinsulinemic-euglycemic clamp, oral glucose tolerance test, liver fat and intramyocellular lipid by 1H-magnetic resonance spectroscopy.3 month

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026